Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2010 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01182584
First received: August 12, 2010
Last updated: December 21, 2010
Last verified: December 2010

August 12, 2010
December 21, 2010
December 2009
October 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01182584 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
Application of Digital Infrared Thermal Imaging in Thyroid Disease and Associated Ophthalmopathy and Dermopathy

Graves' disease is characterized by thyrotoxicosis, goiter, ophthalmopathy and dermopathy. Pathogenesis involves autoimmune process. The investigators think temperatures of the area involved in the inflammation may change. Thus the investigators plan to take temperature pictures of Graves' patients using digital infrared thermal imaging system and observe the change.

We will recruited patients of Graves' disease from out patient clinics. We will perform thyroid echo and soft tissue echo first. Then we let patients sit before the thermal camera and take thermal images of eyes necks and tibia. After data collection, we analyse the relation between temperature and laboratory data such as thyroid function and autoimmune profiles.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Graves' disease patients with or without ophthalmopathy and dermopathy

Graves' Disease
Not Provided
  • Graves' disease
  • Healthy volunteers
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
200
December 2011
October 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Graves' disease patients. Healthy people

Exclusion Criteria:

  • Pregnancy. <16 years old or > 60 years old
Both
16 Years to 60 Years
Yes
Contact: Shyang-Rong Shih, M.D. 0972653337 srshih@ntu.edu.tw
Taiwan
 
NCT01182584
200811040R
Yes
National Taiwan university
National Taiwan University Hospital
Not Provided
Principal Investigator: Shyang-Rong Shih National Taiwan University
National Taiwan University Hospital
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP